Cleared Traditional

K190564 - Rightest Blood Glucose Monitoring Syste...

K190564 is the FDA 510(k) clearance for Rightest Blood Glucose Monitoring Syste... by Bionime Corporation. It is a Class 2 Chemistry device (product code NBW) cleared through the Traditional 510(k) pathway after a 89-day FDA review.

K190564 · Bionime Corporation · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2019
Decision
89d
Days
Class 2
Risk

K190564 is an FDA 510(k) clearance for the Rightest Blood Glucose Monitoring System GM700S, Rightest Blood Glucose Monit.... Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Bionime Corporation (Taichung City, TW). The FDA issued a Cleared decision on June 2, 2019 after a review of 89 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bionime Corporation devices

Submission Details

510(k) Number K190564 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 05, 2019
Decision Date June 02, 2019
Days to Decision 89 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
1d slower than avg
Panel avg: 88d · This submission: 89d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Consultant

Dynamic Biotech, Inc. Dba. Ivdd Regulatory Consultant
Feng-Yu Lee

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 235
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K190564.
On Call Express II Blood Glucose Monitoring System
K192175 · ACON Laboratories, Inc. · Oct 2019
On Call Express Voice Blood Glucose Monitoring System
K191038 · ACON Laboratories, Inc. · Jun 2019
TD-4183 Blood Glucose Monitoring System
K190579 · Taidoc Technology Corporation · Jun 2019
GlucoLeader Enhance Blood Glucose Monitoring System
K182428 · Hmd Biomedical, Inc. · May 2019
GLUCOCARD® W onyx Blood Glucose Monitoring System
K183306 · Arkray Factory, Inc. · Apr 2019
iHealth Wireless Smart Gluco-Monitoring System (iHealth Gluco+)
K181070 · Andon Health Co, Ltd. · Feb 2019